Appendix G.    AS2 Header Attributes

In addition to tarring/gzipping the actual documents, AS2 submissions must include the following attributes in their AS2 headers. The additional information is comprised of:

 

FDA submissions Type

FdaSubmissionType: Abbreviated New Drug (add submission type information)

 

Center Name

FdaCenter: CDER (add Center information)

 

The Mime Headers are to be located in the outermost MIME wrapper and will appear as follows:

 

X-Cyclone-Metadata-FdaSubmissionType: Abbreviated New Drug

X-Cyclone-Metadata-FdaCenter: CDER

 

The following example represents how the standard AS2 mime header should appear after appending the Center and SubmissionType attributes and upon and presented at the FDA ESG.

 

Message-ID: <1115406057162.328983@WIN2K3-ESX6>

Date: Fri, 06 May 2005 19:00:57 GMT

From: esx6

Mime-Version: 1.0

Content-Type: application/pkcs7-mime; smime-type=enveloped-data;

name=smime.p7m

Content-Transfer-Encoding: binary

Content-Disposition: attachment; filename=smime.p7m

Disposition-Notification-To: esx6

Disposition-Notification-Options: signed-receipt-protocol=optional,

pkcs7-signature; signed-receipt-micalg=optional, sha1

AS2-Version: 1.1

AS2-To: db-as2

AS2-From: esx6-as2

X-Cyclone-Metadata-FdaSubmissionType: EANDA

X-Cyclone-Metadata-FdaCenter: CDER

Content-Length: 3607

 

This information must be included in the outermost portion of the outermost MIME wrapper.

 

The table below indicates the allowable attribute values for each FDA Center destination:

 

Table G‑1: Allowable Center Attribute Values

Center Destination

Allowed Attribute Values

CBER

AERS

AERS Attachments

EBLA

ECTD

EIDE

EIND

eDMF

Promotional_Material

Lot_Distribution_Data

CDER

AERS

AERS Attachements

EANDA

EBLA

ECTD

ENDA

EIND

CDRH

Adverse Events

Electronic Submissions

CVM

Electronic_Submissions